Clinical Trial Update: Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

Trial update on Ginkgo Diterpene Lactone Meglumine Injection for ischemic stroke (Phase 2/Phase 3). No results are reported yet and the current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ginkgo Diterpene Lactone Meglumine Injection (Ginkgo diterpene lactone meglumine)

Snippet

Sponsor: RenJi Hospital | Conditions: Ischemic Stroke | Phase 2, Phase 3 | Status: UNKNOWN